Clinical trial
ImproveR International (BI-001-IM)
NCT00290849 · Nycomed, Industry · Completed
Key facts
| NCT number | NCT00290849 |
|---|---|
| Title | ImproveR International (BI-001-IM) |
| Official title | European Registry of Consecutive Patients Undergoing PCI Evaluating the Use of the Thrombin-specific Anticoagulant Bivalirudin With Focus on Patient Selection, Convenience and Safety Aspects. |
| Lead sponsor | Nycomed, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Thrombin-specific Anticoagulant Bivalirudin During Percutaneous Coronary Intervention (PCI) |
| Intervention type | Drug |
| Interventions | Bivalirudin |
| Enrollment | 4,000 |
| Start date | Mar 1, 2005 |
| Primary completion | Jun 1, 2006 |
| Completion | Sep 1, 2007 |
| First posted | Feb 13, 2006 |
| Last update posted | May 7, 2012 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: